AJOONI vs MGEL: Stock Comparison
MANGALAM GLOBAL ENT is the larger company by market capitalisation. AJOONI BIOTECH shows faster revenue growth, lower leverage and a higher net margin, while MANGALAM GLOBAL ENT shows a higher ROE, a higher dividend yield and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AJOONI leads 4; MGEL leads 7 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AJOONI | MGEL |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Animal Feed | Other Agricultural Products |
Price
| Metric | AJOONI | MGEL |
|---|---|---|
| Live Price | ₹3.42 | ₹15.52 |
| Day Change | -1.44% | -2.14% |
| Volume | 2.89 L | 1.79 L |
| 52-Week High | ₹5.94 | ₹18.4 |
| 52-Week Low | ₹3.4 | ₹9.53 |
| Distance from 52W High | -42.42% | -15.65% |
Valuation
| Metric | AJOONI | MGEL |
|---|---|---|
| Market Cap | ₹59 Cr | ₹511 Cr |
| P/E Ratio | — | 10.31x |
| P/B Ratio | — | 1.96x |
| EPS | ₹0.25 | ₹0.26 |
| Book Value | ₹4.81 | ₹7.53 |
| Dividend Yield | 0% | 0.06% |
Growth
| Metric | AJOONI | MGEL |
|---|---|---|
| Revenue Growth (TTM YoY) | 103.3% | 24.92% |
| EPS Growth (TTM YoY) | -44.4% | -32.83% |
| Qtr Sales Growth | 4.73% | 19.28% |
| Qtr Profit Growth | -54.41% | 11.92% |
Profitability & Leverage
| Metric | AJOONI | MGEL |
|---|---|---|
| ROE | 4.74% | 17.49% |
| ROCE | 4.49% | 14.92% |
| Net Margin | 2.34% | 1.34% |
| Operating Margin | 3.55% | 2.58% |
| Debt to Equity | 0.19x | 0.59x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | AJOONI | MGEL |
|---|---|---|
| Promoter Holding | 26.89% | 72.38% |
| FII Holding | 0% | 0.09%▼ 0.09 pp |
| DII Holding | 0% | 0% |
| Public Holding | 73.11% | 27.53%▲ 0.09 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AJOONI BIOTECH and MANGALAM GLOBAL ENT.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.